Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer

被引：1

作者：

Khatib, Jude ^{[1
]}

Kainthla, Radhika ^{[1
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Hematol & Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA

来源：

CURRENT COLORECTAL CANCER REPORTS | 2020年 / 16卷 / 04期

关键词：

FOLFOXIRI; Bevacizumab; Metastatic colorectal cancer; Conversion therapy; First-line therapy; RANDOMIZED-TRIAL; OPEN-LABEL; RESECTION; CHEMOTHERAPY; MANAGEMENT; CONSENSUS; SURVIVAL; PHASE-3;

D O I：

10.1007/s11888-020-00455-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose of Review Colorectal cancer is the second leading cause of cancer-related deaths in the USA with more than half of diagnosed patients developing metastatic disease. The mainstay of treatment for metastatic disease is chemotherapy, and upfront treatment has generally consisted of a two-drug chemotherapy combination (FOLFOX or FOLFIRI) plus a biologic agent. In this review, we explore the emerging role of the three-drug chemotherapy combination FOLFOXIRI plus bevacizumab as first-line treatment in metastatic colorectal cancer. Recent Findings Randomized trials evaluating the efficacy of FOLFOXIRI plus bevacizumab have shown improvement in objective response rate, overall survival, and resection rate when compared to previous standard therapy. However, this comes with added toxicity, which can be one of the main barriers to its widespread implementation. FOLFOXIRI plus bevacizumab is an effective therapy in carefully selected patients; however, more clinical trials investigating the regimen's role in colorectal cancer remain a significant need.

引用

页码：89 / 95

页数：7

共 21 条

[11] Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer [J].

Loupakis, Fotios ;

Cremolini, Chiara ;

Masi, Gianluca ;

Lonardi, Sara ;

Zagonel, Vittorina ;

Salvatore, Lisa ;

Cortesi, Enrico ;

Tomasello, Gianluca ;

Ronzoni, Monica ;

Spadi, Rosella ;

Zaniboni, Alberto ;

Tonini, Giuseppe ;

Buonadonna, Angela ;

Amoroso, Domenico ;

Chiara, Silvana ;

Carlomagno, Chiara ;

Boni, Corrado ;

Allegrini, Giacomo ;

Boni, Luca ;

Falcone, Alfredo .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17) :1609-1618

[12] Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial [J].

Masi, Gianluca ;

Loupakis, Fotios ;

Salvatore, Lisa ;

Fornaro, Lorenzo ;

Cremolini, Chiara ;

Cupini, Samanta ;

Ciarlo, Andrea ;

Del Monte, Francesca ;

Cortesi, Enrico ;

Amoroso, Domenico ;

Granetto, Cristina ;

Fontanini, Gabriella ;

Sensi, Elisa ;

Lupi, Cristiana ;

Andreuccetti, Michele ;

Falcone, Alfredo .

LANCET ONCOLOGY, 2010, 11 (09) :845-852

[13]

Nemoto Tetsutaro, 2019, Gan To Kagaku Ryoho, V46, P2410

[14] Randomized phase Ill study comparing FOLFOX plus bevacizumab versus folfoxiri plus bevacizumab (BEV) as 1st line treatment in patients with metastatic colorectal cancer (mCRC) with ≥3 baseline circulating tumor cells (bCTCs). [J].

Sastre, Javier ;

Maria Vieitez, Jose ;

Auxilidora Gomez-Espana, Maria ;

Gil Calle, Silvia ;

Salud Salvia, Antonieta ;

Grana Suarez, Begona ;

Garcia-Alfonso, Pilar ;

Martinez de Castro, Eva ;

Quintero Aldana, Guillermo Alfonso ;

Jose Reina-Zoilo, Juan ;

Gonzalez Flores, Encarnacion ;

Salgado Fernandez, Mercedes ;

Guillen, Carmen ;

Garcia-Carbonero, Rocio ;

Jose Safont, Maria ;

La Casta Munoa, Adelaida ;

Garcia de Paredes, Beatriz ;

Lopez, Rafael ;

Aranda, Enrique ;

Diaz-Rubio, Eduardo .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[15] "CHARTA": FOLFOX/Bevacizumab vs. FOLFOXIRI/Bevacizumab in advanced colorectal cancer-Final results, prognostic and potentially predictive factors from the randomized Phase II trial of the AIO. [J].

Schmoll, Hans-Joachim ;

Meinert, Fabian Maximilian ;

Cygon, Franziska ;

Garlipp, Benjamin ;

Junghanss, Christian ;

Leithauser, Malte ;

Schaefers, Michael ;

Kaiser, Ulrich ;

Hoeffkes, Heinz-Gert ;

Florschutz, Axel ;

Russel, Jorn ;

Kanzler, Stephan ;

Edelmann, Thomas ;

Forstbauer, Helmut ;

Goehler, Thomas ;

Hannig, Carla ;

Hildebrandt, Bert ;

Steighardt, Jorg .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[16] Surgical Management of Hepatic Metastases of Colorectal Cancer [J].

Smith, J. Joshua ;

D'Angelica, Michael I. .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (01) :61-+

[17] FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis [J].

Tomasello, Gianluca ;

Petrelli, Fausto ;

Ghidini, Michele ;

Russo, Alessandro ;

Passalacqua, Rodolfo ;

Barni, Sandro .

JAMA ONCOLOGY, 2017, 3 (07)

[18] ESMO consensus guidelines for the management of patients with metastatic colorectal cancer [J].

Van Cutsem, E. ;

Cervantes, A. ;

Adam, R. ;

Sobrero, A. ;

Van Krieken, J. H. ;

Aderka, D. ;

Aranda Aguilar, E. ;

Bardelli, A. ;

Benson, A. ;

Bodoky, G. ;

Ciardiello, F. ;

D'Hoore, A. ;

Diaz-Rubio, E. ;

Douillard, J. -Y. ;

Ducreux, M. ;

Falcone, A. ;

Grothey, A. ;

Gruenberger, T. ;

Haustermans, K. ;

Heinemann, V. ;

Hoff, P. ;

Koehne, C. -H. ;

Labianca, R. ;

Laurent-Puig, P. ;

Ma, B. ;

Maughan, T. ;

Muro, K. ;

Normanno, N. ;

Osterlund, P. ;

Oyen, W. J. G. ;

Papamichael, D. ;

Pentheroudakis, G. ;

Pfeiffer, P. ;

Price, T. J. ;

Punt, C. ;

Ricke, J. ;

Roth, A. ;

Salazar, R. ;

Scheithauer, W. ;

Schmoll, H. J. ;

Tabernero, J. ;

Taieb, J. ;

Tejpar, S. ;

Wasan, H. ;

Yoshino, T. ;

Zaanan, A. ;

Arnold, D. .

ANNALS OF ONCOLOGY, 2016, 27 (08) :1386-1422

[19] Towards a pan-European consensus on the treatment of patients with colorectal liver metastases [J].

Van Cutsem, Eric ;

Nordlinger, Bernard ;

Adam, Rene ;

Koehne, Claus-Henning ;

Pozzo, Carmelo ;

Poston, Graeme ;

Ychou, Marc ;

Rougier, Philippe .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) :2212-2221

[20] Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab [J].

Yoo, Peter S. ;

Lopez-Soler, Reynold I. ;

Longo, Walter E. ;

Cha, Charles H. .

CLINICAL COLORECTAL CANCER, 2006, 6 (03) :202-207

← 1 2 3 →